Have a feature idea you'd love to see implemented?
Let us know!
RLYB Rallybio Corp
Price (delayed)
$0.9886
Market cap
$41.01M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.59
Enterprise value
$15.92M
Highlights
Rallybio's gross profit has soared by 100% from the previous quarter
RLYB's revenue has soared by 100% from the previous quarter
The quick ratio has contracted by 29% YoY but it has grown by 26% from the previous quarter
The equity has declined by 43% year-on-year and by 11% since the previous quarter
Key stats
What are the main financial stats of RLYB
Market
Valuations
Earnings
Shares outstanding
41.49M
Market cap
$41.01M
Enterprise value
$15.92M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.58
Price to sales (P/S)
73.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
26.63
Revenue
$598,000
EBIT
-$66.97M
EBITDA
-$66.84M
Free cash flow
-$51.08M
Per share
Balance sheet
Liquidity
EPS
-$1.59
Free cash flow per share
-$1.15
Book value per share
$1.71
Revenue per share
$0.01
TBVPS
$1.77
Total assets
$79.01M
Total liabilities
$8.19M
Debt
$230,000
Equity
$70.82M
Working capital
$70.04M
Debt to equity
0
Current ratio
9.55
Quick ratio
9.18
Net debt/EBITDA
0.38
Margins
Efficiency
Dividend
EBITDA margin
-11,176.6%
Gross margin
100%
Net margin
-11,199.5%
Operating margin
-11,705.7%
Return on assets
-69.3%
Return on equity
-77.4%
Return on invested capital
-102.2%
Return on capital employed
-94.6%
Return on sales
-11,199.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RLYB stock price
How has the Rallybio stock price performed over time
Intraday
-0.55%
1 week
-2.12%
1 month
-10.13%
1 year
-58.81%
YTD
-58.64%
QTD
-15.5%
Financial performance
How have Rallybio's revenue and profit performed over time
Revenue
$598,000
Gross profit
$598,000
Operating income
-$70M
Net income
-$66.97M
Gross margin
100%
Net margin
-11,199.5%
Rallybio's gross profit has soared by 100% from the previous quarter
RLYB's revenue has soared by 100% from the previous quarter
RLYB's net margin has soared by 55% since the previous quarter
Rallybio's operating margin has soared by 55% from the previous quarter
Growth
What is Rallybio's growth rate over time
Valuation
What is Rallybio stock price valuation
P/E
N/A
P/B
0.58
P/S
73.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
26.63
The EPS is up by 11% since the previous quarter and by 11% year-on-year
The equity has declined by 43% year-on-year and by 11% since the previous quarter
RLYB's price to book (P/B) is 28% lower than its last 4 quarters average of 0.8
RLYB's revenue has soared by 100% from the previous quarter
Efficiency
How efficient is Rallybio business performance
RLYB's return on equity has dropped by 61% year-on-year and by 4.5% since the previous quarter
The ROIC has dropped by 60% year-on-year and by 11% since the previous quarter
The ROS has soared by 55% since the previous quarter
Rallybio's return on assets has shrunk by 53% YoY and by 3.3% QoQ
Dividends
What is RLYB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RLYB.
Financial health
How did Rallybio financials performed over time
The total assets has declined by 41% year-on-year and by 15% since the previous quarter
Rallybio's total liabilities has decreased by 34% from the previous quarter and by 15% YoY
RLYB's debt is 100% smaller than its equity
RLYB's debt is down by 46% year-on-year and by 19% since the previous quarter
The equity has declined by 43% year-on-year and by 11% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.